Literature DB >> 6744532

Calcium, sodium, and the calcium paradox.

W G Nayler, S E Perry, J S Elz, M J Daly.   

Abstract

The effect of "sodium loading," of verapamil and of nifedipine on the gain in calcium and sodium, and on the loss of myoglobin, during the calcium paradox in adult rat hearts was examined. Raising cell sodium from 56.5 +/- 2.6 to 129.5 +/- 10.2 mumol sodium/gram dry weight did not alter the degree or rate of calcium gain or myoglobin release during calcium repletion after long periods (greater than 2 minutes) of calcium-free perfusion; under these conditions, and in the presence of 10 micrograms/liter verapamil, calcium gain was enhanced. However, after shorter periods (0.5-1.5 minutes), of calcium-free perfusion, calcium gain was enhanced in "sodium-loaded" hearts, even in the absence of verapamil, and particularly during the early stages of repletion. The presence of 1 and 10 mumol/liter dl-verapamil and 1 mumol/liter nifedipine before, during, and after 10 minutes of calcium-free perfusion significantly (P less than 0.01) slowed the early (up to 1 minute for verapamil and 2 minutes for nifedipine) but not the late gain in calcium. When verapamil was present, the late gain in calcium was actually enhanced. These agents also abolished the early (45 seconds) but not the late (greater than 2 minutes) gain in sodium that occurs during repletion. We propose that the gain in calcium that occurs during calcium repletion after a period of calcium-free perfusion can be divided into at least two phases (early and late), and that the early phase contains a verapamil/nifedipine-sensitive component and a verapamil/nifedipine-insensitive component, the latter probably involving sodium-calcium exchange.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6744532     DOI: 10.1161/01.res.55.2.227

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  23 in total

1.  Nifedipine and experimental cardioprotection.

Authors:  W G Nayler; J J Liu; S Panagiotopoulos
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

2.  Myocardial cAMP and calcium levels in the calcium paradox.

Authors:  S Rotevatn; H Jodalen; J Røli; D Ogreid; A N Oksendal; P Jynge
Journal:  Basic Res Cardiol       Date:  1986 Jul-Aug       Impact factor: 17.165

3.  Characterization of the calcium paradox in the isolated perfused frog heart: enzymatic, ionic, contractile and electrophysiological studies.

Authors:  M Touraki; I Beis
Journal:  J Comp Physiol B       Date:  1990       Impact factor: 2.200

4.  Myocardial protection by micromolar manganese in the calcium paradox and additive effects of verapamil.

Authors:  A N Oksendal; P Jynge
Journal:  Basic Res Cardiol       Date:  1986 Nov-Dec       Impact factor: 17.165

5.  Depression of action potential characteristics and a decreased space constant are present in postischemic, reperfused myocardium.

Authors:  J H Levine; E N Moore; H F Weisman; A H Kadish; L C Becker; J F Spear
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

6.  Polyamines mediate uncontrolled calcium entry and cell damage in rat heart in the calcium paradox.

Authors:  H Koenig; A D Goldstone; J J Trout; C Y Lu
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

7.  Effects of sodium on the calcium paradox in rat hearts.

Authors:  P Busselen
Journal:  Pflugers Arch       Date:  1987-05       Impact factor: 3.657

8.  Effects of hypoxia on relationships between cytosolic and mitochondrial NAD(P)H redox and superoxide generation in coronary arterial smooth muscle.

Authors:  Qun Gao; Michael S Wolin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-20       Impact factor: 4.733

9.  Possible role of phospholipase C in the induction of Ca(2+)-paradox in rat heart.

Authors:  S Persad; A Vrbanova; J T Meij; V Panagia; N S Dhalla
Journal:  Mol Cell Biochem       Date:  1993-04-21       Impact factor: 3.396

10.  Tissue protection by adrenergic blockade in the calcium paradox?

Authors:  A N Oksendal; P Jynge
Journal:  Basic Res Cardiol       Date:  1987 Mar-Apr       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.